Business
CSL open to new manufacturing options after AstraZeneca production – Sydney Morning Herald
The biotech giant says it can hit the 50 million dose mark by December and is in talks with the government about how else it can help fight the pandemic.
Biotech giant CSL is in talks with the government about its longer-term role in Australias fight against coronavirus, as the company races to complete 50 million doses of the AstraZeneca vaccine by December.
The $123 billion blood plasma giant confirmed over the weekend that it was now producing more than 1 million doses of the vaccine per week, with more than 3.7 million doses released to the public by the end of April. There is a four-week quality control and approvals process that must be completed…
-
Noosa News21 hours agoOutback October heat records broken in three states
-
General22 hours agoMonash IVF strips former execs of bonuses after mix-ups
-
General22 hours agoChina fighter jet flares scare sparks Australian alarm
-
Noosa News22 hours agoTristian Frahm: Coroner finds boy’s death from brown snake bite at property near Murgon, Queensland could have been avoided